A new peer-reviewed study is strengthening the case for medical cannabis as a cost-effective treatment for chronic pain—and the findings could reshape how healthcare providers, insurers, and policymakers view cannabis.
Published in the journal Pharmacy, the study analyzed 5,242 chronic pain patients, comparing those who used medical cannabis for at least a year with those who didn’t. The results? Cannabis patients reported fewer urgent care and ER visits, fewer unhealthy days per month, and a higher overall quality of life. Hospitalization rates were also lower, though not statistically significant.
Lead author Mitchell Doucette summed it up: improving quality of life while reducing healthcare utilization shows cannabis isn’t just helping with pain—it’s reducing strain on the healthcare system. That’s a message insurers can’t ignore.
And this study isn’t alone. Prior research has shown:
✔ States with medical marijuana programs have lower health insurance premiums.
✔ Medical cannabis is often as effective—or more effective—than opioids for chronic pain.
✔ Substitution effects are reducing opioid prescriptions and, in some states, overdose deaths.
If insurers begin covering medical cannabis, it could transform patient access, drive wider adoption, and push federal policymakers closer to rescheduling and eventual insurance reimbursement models.
For chronic pain patients, this means better outcomes and fewer ER visits. For healthcare systems, it means lower costs. And for investors, it’s another sign that medical cannabis could become a mainstream part of the healthcare economy sooner than many expect.
#MedicalCannabis #ChronicPain #CannabisResearch #CannabisPolicy #HealthcareCosts #OpioidAlternative #CannabisInvesting #CannabisNews #TradeToBlack #CannabisReform
Want to see last week’s recap?
https://youtu.be/XzmLDM2Ksek
Want to see more Cannabis Reform videos?
https://youtu.be/OE2b4FKLhJ0
https://youtu.be/pIvhV-ESpNM
https://youtu.be/rbE4W6nNFGw
https://youtu.be/s6V9hfUE10g
Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com/subscribe
Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook: https://www.facebook.com/TheDalesReport
Twitter: https://twitter.com/TheDalesReport
Instagram: https://www.instagram.com/dalesreport
LinkedIn: https://www.linkedin.com/company/the-dales-report/
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackonApplePodcasts
Spotify: https://tinyurl.com/TDRTradeToBlackonSpotify
Website: https://thedalesreport.com/
For copyright matters, please get in touch with us at:
[email protected]
All views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have.
https://thedalesreport.com/website-terms-of-use/
